Two-channel IV-PCA With Dexmedetomidine

Status Recruiting

Clinical Trial Summary

Dexmedetomidine was administered in the 'selector' channel and fentanyl in the 'basic & bolus' channel of dual channel intravenous patient-controlled analgesia (IV-PCA) and the amount of opioid consumption was compared. In addition, intensity of pain, postoperative nausea/vomiting, and postoperative delirium was evaluated.

Clinical Trial Description

Bellomic® (Cebika, Uiwang-si, Gyeonggi-do, South Korea), a new IV-PCA device consisting of two separate drug pump channels, can be used in various ways and is expanding its scope of use. Unlike conventional IV-PCA devices, which have been used to mix and administer all drugs in one channel, the device can inject drugs separately in two channels. One channel (Selector & Bolus) allows the patient to control whether to take additional bolus medication by pressing the button with adjustable continuous infusion, while the other channel (Continuous) allows constant rate continuous infusion. Dexmedetomidine is a selective alpha-2 agonist, which is widely used in intensive care unit management, surgery, and various procedures because it has the advantage of less respiratory suppression along with sedation/anesthesia and pain effects. It has been previously reported that postoperative pain, morphine usage, and nausea/vomiting can be reduced when used during/after surgery in addition to general anesthetic drugs. However, in terms of major abdominal surgery, there is no research related to the use of dexmedetomidine after surgery, even though a large amount of opioid agents are required due to severe acute pain. Thus, the investigators planned a randomized controlled trial to investigate the effectiveness dexmedetomidine using dual-chamber IV-PCA. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05672225
Study type	Interventional
Source	Korea University Guro Hospital
Contact	Seok Kyeong Oh, M.D., Ph.D
Phone	82-2-2626-3237
Email	nanprayboy@korea.ac.kr
Status	Recruiting
Phase	N/A
Start date	February 7, 2023
Completion date	December 31, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04577430` - Effects of Dexmedetomidine on Cardiac Electrophysiology in Patients Under General Anesthesia During Perioperative Period	N/A
Completed	`NCT03220880` - Intranasal Dexmedetomidine Sedation in Children for Non-painful Procedures
Completed	`NCT05291364` - Dexmedetomidine in Splanchnic Nerve Neurolysis	N/A
Recruiting	`NCT05249153` - Dexmedetomidine and Sufentanil Effect in PCA on Pediatric Patients Undergoing Scoliosis Surgery	N/A
Completed	`NCT01688648` - Comparison Between Lidocaine, Dexmedetomidine, and Their Combined Infusion in Subjects Undergoing Coronary Artery Bypass Graft	N/A
Completed	`NCT05103735` - Propofol-remifentanyl Versus Dexmedetomidine in Awake Craniotomy: Impact on Electroclinical Seizure Activity
Recruiting	`NCT06030804` - Perioperative Dexmedetomidine and Long-term Survival After Cancer Surgery	N/A
Terminated	`NCT03253224` - Magnesium and Postoperative Pain	Phase 4
Recruiting	`NCT06210061` - Propofol-Fentanyl-Dexmedetomidine and Propofol-Fentanyl-Sevoflurane Anesthesia for Major Spine Surgery Under Somato Sensory- and Motor- Evoked Potential Monitoring	N/A
Recruiting	`NCT05525819` - Intrathecal Versus Intravenous Dexmedetomidine in Prostate Transurethral Resection	N/A
Completed	`NCT04665453` - Dexmedetomidine and Melatonin for Sleep Induction for EEG in Children	N/A
Completed	`NCT06018948` - Effect of Two Different Doses of Dexmedetomidine Infusion in Morbidly Obese Patients	Phase 4
Completed	`NCT03775655` - Low Dose Hyperbaric Bupivacaine and Dexmedetomidine as an Adjuvant, Caesarean Section	Phase 2/Phase 3
Completed	`NCT03658421` - Dexmedetomidine as Adjuvant for FNB in TKA	N/A
Completed	`NCT03234660` - Dexmedetomidine and Neuroprotection in Children Undergoing General Anesthesia	N/A
Completed	`NCT06020781` - Efficacy and Safety of Dexmedetomidine to Bupivacaine in Supraclavicular Brachial Plexus Block	N/A
Recruiting	`NCT06207331` - Effects of Atomized Dexmedetomidine on Lung Function in Patients With Chronic Obstructive Pulmonary Disease	N/A
Active, not recruiting	`NCT03629262` - Dexmedetomidine Supplemented Intravenous Analgesia in Elderly After Orthopedic Surgery	Phase 4
Recruiting	`NCT06098209` - Dexmedetomidine and Propofol in Mechanically Ventilated Patients by Using Salivary Alpha-amylase as a Stress Marker	N/A
Not yet recruiting	`NCT06062550` - Different Dose Esketamine and Dexmedetomidine Combination for Supplemental Analgesia After Scoliosis Correction Surgery	Phase 4